History
Naobios: 20 years of recognized expertise in cell culture and virus production
2024
Major upgrade!
Two of our Grade A/B GMP suites were fully revamped—brand-new, fully operational, and equipped with cutting-edge technology.
2021
We upgraded our BSL2+ suite to BSL3, bolstering our ability to handle high‑risk virology safely and reliably
March 2019
A new era emerged: Our facility joined Clean Biologics group and became Naobios. Our mission shifted to full CDMO services, operating alongside Clean Cells, our sister company — streamlining development and clinical-grade production for viral vaccines and vectors.
2019 and beyond
a new history of Contract Development and Manufacture for global sponsors
2016
The warehouse was relocated externally to create new offices and meeting rooms—laying the groundwork for further expansion.
2014
We scaled up—adding a 4th BSL2+ clinical manufacturing suite and a new biostorage unit increased production capacity and efficiency.
November 2013
Acquired by Biological E Limited and operating as BE Vaccines SAS, our facility supported vaccine development, GMP production, and tech transfers to India.
2013 to 2019
consolidation of an international GMP experience and handling of sensitive products
2005
Founded in Saint‑Herblain by Vivalis, our facility began its journey focused on cell-line development, R&D, and GMP for early-stage biologics.
A bold foundation for future breakthroughs.
2005 to 2013
Construction of the site and development of a specialized know-how